Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

Running, not enrolling · Phase 1

Conditions studied: Multiple Myeloma

In brief

Subjects are enrolled in this study following completion or early discontinuation from a Poseida sponsored or supported study of P-BCMA-101 T cells and will be followed for a total of 15 years post treatment from the last P-BCMA-101 treatment. Subjects will be monitored for safety and efficacy to assess the risk of delayed adverse events (AEs) and assess long-term efficacy, and PK and quantification of P-BCMA-101 T cells. Rimiducid may be administered as indicated.

Key facts

Study ID

NCT03741127

Run by

Poseida Therapeutics, Inc.

People needed

100

Starts

2018-10-29

Expected to finish

2032-11-01

Last updated by the study team

2026-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have received P-BCMA-101 and completed or discontinued early from a Poseida sponsored treatment protocol.
• Subject has provided informed consent.

You may not qualify if…

• None

Where it is running

• University of California Davis — Davis, California, United States
• University of California, San Diego — San Diego, California, United States
• University of California San Francisco — San Francisco, California, United States
• Colorado Blood Cancer Institute — Denver, Colorado, United States
• University of Chicago — Chicago, Illinois, United States
• University of Kansas Cancer Center — Westwood, Kansas, United States
• University of Maryland Greenebaum Comprehensive Cancer Center — Baltimore, Maryland, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Wayne State - Karmanos Cancer Institute — Detroit, Michigan, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Sarah Cannon Research Institute at Tennessee Oncology — Nashville, Tennessee, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.